Interviews

Download PDF

Register to download the report. Already a member?

 
 
Sign Up

Or

62462 1502285060HCLSReviewMexicoJuly2017.pdf
Energy Boardroom

Pharma Interviews


Filter

Interview: Y.M. Dennis Lo – Co-Founder, Cirina; Professor of Chemical Pathology, Faculty of Medicine, The Chinese University of Hong Kong (CUHK), Hong Kong

Described as the first unicorn [a startup company valued at over USD 1 billion] of Hong Kong, Cirina has recently merged with Grail to further improve detection of cancer at its early stage. Pharmaboardroom sat down with Professor Denis Lo, …

18.08.2017

Interview: Roman Gladkyi – General Manager, Ferring Ukraine

Roman Gladkyi, general manager of Ferring Ukraine, describes the current opportunities and areas for improvement he identifies within Ukraine’s pharmaceutical market and the country’s evolving heath system, with a special focus on Ferring’s key areas of expertise such as reproductive …

18.08.2017


Interview: Charles Ng – Associate Director-General; Simon Tsang – Head of Innovation and Technology, InvestHK, Hong Kong

Charles Ng and Simon Tsang of InvestHK, Hong Kong’s investment promotion agency, discuss the territory’s strengths in the life sciences sector, the potential of the HK industry to grow further, and its regional significance. The Swiss-based International Institute for Management …

18.08.2017

Interview: Christoph Zielinski – Head of the Organizational Unit, Comprehensive Cancer Center of Vienna, Austria

Dr. Christoph Zielinski, head of the organizational unit of the Comprehensive Cancer Center of Vienna (CCC), a representative of the Austrian oncological community, provides an insight into the key activities of the center. He also gives an overview of the …

17.08.2017


Interview: Scott Curley – General Manager, Astra Zeneca Hong Kong

Scott Curley, general manager of Astra Zeneca Hong Kong, discusses how his affiliate managed to achieve its successful product launch track record; shares his insights on the key specificities of Hong Kong and further explains why it is an important …

17.08.2017

Interview: Marlia Hayati Goestam – President Director & Joey Romana – Vice President Director, PT Darya-Varia Laboratoria, Indonesia

Marlia Hayati and Joey Romana, President Director and Vice President Director at PT Darya-Varia Laboratoria, share insights about the company’s strong brand equity and pioneering manufacturing strategy. In 2016, the sales growth rate achieved by Darya-Varia Laboratoria was 11 percent, …

17.08.2017


Interview: Dr. Christopher Cheng – Managing Director, Hong Kong Institute of Biotechnology (HKIB)

Professor Cheng, managing director of the Hong Kong Institute of Biotechnology, introduces the organization’s mission to improve development of biotechnology and traditional Chinese medicine sectors as well as the main challenges ahead. What is the mandate of the Hong Kong …

17.08.2017

Interview: Haris Izmee – Director, GE Healthcare Indonesia

Haris Izmee, director at GE Healthcare Indonesia, explains the strong commitment of the company towards improving access, affordability and quality and highlights the company’s significant investments in internal capabilities and education. The former global President & CEO of GE Healthcare, …

17.08.2017


Interview: Alexandre de Muralt – Managing Director, Merck Healthcare, Hong Kong; General Manager, Merck Biopharma, Taiwan

Alexandre de Muralt, the man behind Merck’s operations in Hong Kong and Taiwan discusses the nuances of these two local markets. In addition, he shares his insights on how Merck’s transformation has impacted local affiliates. Can you begin by telling …

17.08.2017

Interview: Maura Linda Sitanggang – Director General, Ministry of Health, Indonesia

Maura Linda Sitanggang, director general at the Indonesian Ministry of Health, discusses the plans being rolled out to ensure that all Indonesians have access to medicines and how the Indonesian pharmaceutical industry has developed its self-reliance and innovativeness. How does …

17.08.2017


Interview: Harald Isemann – Chairman, Vienna Biocenter (VBC) & Managing Director, Institute of Molecular Pathology (IMP), Austria

Harald Isemann, chairman of the Vienna Biocenter (VBC) – one of the leading life science hubs in Europe – and Managing Director of the Institute of Molecular Pathology (IMP), a VBC member, provides insights into the main tasks of the …

17.08.2017

Interview: Evgeniy Gaydukov – Country Director, AstraZeneca Ukraine

Evgeniy Gaydukov, Country Director of AstraZeneca Ukraine, provides insights into the remarkable growth that the science-led, innovative company has been experiencing in Ukraine despite the unstable economic situation in the country, as well as the socially oriented, collaborative, and patient-centric …

17.08.2017


LATEST ISSUE

DOWNLOAD

X
Download PDF

First Name:

Last Name:

Company:

Position:

Country:

Email: